Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants

被引:14
|
作者
Madewell, Zachary J. [1 ]
Yang, Yang [2 ]
Longini, Ira M., Jr. [1 ]
Halloran, M. Elizabeth [3 ,4 ]
Vespignani, Alessandro [5 ]
Dean, Natalie E. [6 ]
机构
[1] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA
[2] Univ Georgia, Dept Stat, Athens, GA USA
[3] Univ Washington, Dept Biostat, Seattle, WA USA
[4] Fred Hutchinson Canc Ctr, Seattle, WA USA
[5] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA USA
[6] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
Serial interval; Generation time; COVID-19; Symptom onset; Generation interval; Incubation period; TRANSMISSION DYNAMICS; COVID-19; CORONAVIRUS; OUTBREAK; PROVINCE; CHINA;
D O I
10.1186/s12879-023-08407-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The serial interval is the period of time between symptom onset in the primary case and symptom onset in the secondary case. Understanding the serial interval is important for determining transmission dynamics of infectious diseases like COVID-19, including the reproduction number and secondary attack rates, which could influence control measures. Early meta-analyses of COVID-19 reported serial intervals of 5.2 days (95% CI: 4.9-5.5) for the original wild-type variant and 5.2 days (95% CI: 4.87-5.47) for Alpha variant. The serial interval has been shown to decrease over the course of an epidemic for other respiratory diseases, which may be due to accumulating viral mutations and implementation of more effective nonpharmaceutical interventions. We therefore aggregated the literature to estimate serial intervals for Delta and Omicron variants. Methods This study followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A systematic literature search was conducted of PubMed, Scopus, Cochrane Library, ScienceDirect, and preprint server medRxiv for articles published from April 4, 2021, through May 23, 2023. Search terms were: ("serial interval" or "generation time"), ("Omicron" or "Delta"), and ("SARS-CoV-2" or "COVID-19"). Meta-analyses were done for Delta and Omicron variants using a restricted maximum-likelihood estimator model with a random effect for each study. Pooled average estimates and 95% confidence intervals (95% CI) are reported. Results There were 46,648 primary/secondary case pairs included for the meta-analysis of Delta and 18,324 for Omicron. Mean serial interval for included studies ranged from 2.3-5.8 days for Delta and 2.1-4.8 days for Omicron. The pooled mean serial interval for Delta was 3.9 days (95% CI: 3.4-4.3) (20 studies) and Omicron was 3.2 days (95% CI: 2.9-3.5) (20 studies). Mean estimated serial interval for BA.1 was 3.3 days (95% CI: 2.8-3.7) (11 studies), BA.2 was 2.9 days (95% CI: 2.7-3.1) (six studies), and BA.5 was 2.3 days (95% CI: 1.6-3.1) (three studies). Conclusions Serial interval estimates for Delta and Omicron were shorter than ancestral SARS-CoV-2 variants. More recent Omicron subvariants had even shorter serial intervals suggesting serial intervals may be shortening over time. This suggests more rapid transmission from one generation of cases to the next, consistent with the observed faster growth dynamic of these variants compared to their ancestors. Additional changes to the serial interval may occur as SARS-CoV-2 continues to circulate and evolve. Changes to population immunity (due to infection and/or vaccination) may further modify it.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS-CoV-2 variants
    Ursic, Tina
    Kogoj, Rok
    Sikonja, Jaka
    Roskaric, Damijana
    Virant, Monika Jevsnik
    Bogovic, Petra
    Petrovec, Miroslav
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4704 - 4711
  • [42] Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households
    Jorgensen, Silje B.
    Nygard, Karin
    Kacelnik, Oliver
    Telle, Kjetil
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1610 - 1611
  • [43] SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
    Regenhardt, Elisa
    Kirsten, Holger
    Weiss, Melanie
    Luebbert, Christoph
    Stehr, Sebastian N.
    Remane, Yvonne
    Pietsch, Corinna
    Hoenemann, Mario
    von Braun, Amrei
    VACCINES, 2023, 11 (05)
  • [44] Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants
    Feng, Sheng
    Fan, Zechang
    Zhou, Keyue
    Ma, Shanshan
    Liang, Mingzheng
    Zhang, He
    Xie, Yubiao
    Ha, Zhuo
    Jin, Ningyi
    Lu, Huijun
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (10)
  • [45] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
    Zhao, Hanjun
    To, Kelvin Kai-Wang
    Lam, Hoiyan
    Zhang, Chuyuan
    Peng, Zheng
    Meng, Xinjie
    Wang, Xiankun
    Zhang, Anna Jinxia
    Yan, Bingpeng
    Cai, Jianpiao
    Yeung, Man Lung
    Chan, Jasper Fuk-Woo
    Yuen, Kwok-Yung
    CELL DISCOVERY, 2022, 8 (01)
  • [46] Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
    Lee, Byung Uk
    AEROSOL AND AIR QUALITY RESEARCH, 2022, 22 (01)
  • [47] Omicron variants of SARS-CoV-2 and long COVID
    Yang, Chengliang
    Zhao, Hedi
    Shannon, Casey P.
    Tebbutt, Scott J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
    Jianxia Ou
    Yanan Zhang
    Yongmei Wang
    Zherui Zhang
    Hongping Wei
    Junping Yu
    Qi Wang
    Guifeng Wang
    Bo Zhang
    Chunhe Wang
    Signal Transduction and Targeted Therapy, 7
  • [49] ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
    Ou, Jianxia
    Zhang, Yanan
    Wang, Yongmei
    Zhang, Zherui
    Wei, Hongping
    Yu, Junping
    Wang, Qi
    Wang, Guifeng
    Zhang, Bo
    Wang, Chunhe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [50] The clinical effectiveness of REGEN-COV in SARS-CoV-2 infection with Omicron versus Delta variants
    Gershengorn, Hayley B.
    Patel, Samira
    Ferreira, Tanira
    Das, Sankalp
    Parekh, Dipen J.
    Shukla, Bhavarth
    PLOS ONE, 2022, 17 (12):